Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a major global cancer, with immunotherapy resistance affecting over 70% of patients.
• Epigenetic modifications are increasingly recognized for their role in HNSCC initiation and progression.
• The nuclear receptor binding SET domain (NSD) family, including NSD1-NSD3, is frequently altered in HNSCC.

Purpose of the Study:

• To review the role of NSD protein methyltransferases in HNSCC pathogenesis.
• To highlight the potential of NSD family members as novel therapeutic targets for HNSCC.

Main Methods:

• Literature review of preclinical and clinical studies on NSD family members in HNSCC.
• Analysis of genetic alterations (mutations, amplifications) of NSD genes in HNSCC datasets.
• Synthesis of findings on the oncogenic and tumor-suppressing functions of NSD1, NSD2, and NSD3.

Main Results:

• NSD1 and NSD3 are among the most commonly mutated or amplified genes in HNSCC.
• Preclinical studies indicate diverse roles for NSD1, NSD2, and NSD3, acting as both oncogenes and tumor suppressors in HNSCC.
• The NSD family's involvement in HNSCC pathogenesis is complex and context-dependent.

Conclusions:

• The NSD family of protein methyltransferases plays a significant role in the development of HNSCC.
• Targeting NSD family members presents a promising avenue for developing novel therapies for HNSCC.
• Further research into the specific functions and therapeutic potential of NSD proteins in HNSCC is warranted.